Nuffield Health has launched aquablation therapy, a robotic treatment for men with Benign Prostate Hyperplasia (BPH), at its Parkside and Oxford hospitals. BPH, which affects up to 3 million men in the UK annually, can lead to symptoms such as difficulty urinating, bladder issues, and infections. If left untreated, it may result in severe complications….
Membership Required
You must be a HM Subscriber to view this content.
Already have an account? Sign In
©2025 All rights reserved LaingBuisson 
, at its Parkside and Oxford hospitals.){kind=link}